As psychedelic therapies approach FDA approval, insurance coverage remains limited. Spravato is already covered by some insurers, including Medicare. According to Medicare.org, Part B covers both the drug and monitoring. Third-party providers like Enthea are piloting coverage models similar to dental or vision benefits.
